BRIEF published on 09/09/2026 at 13:25, 27 days 16 hours ago BRAIN Biotech AG obtient un paiement d'étape de 11,51 millions d'euros BRAIN Biotech AG Situation Financière Paiement D'étape Deucrictibant Royal Pharma
BRIEF published on 09/09/2026 at 13:25, 27 days 16 hours ago BRAIN Biotech AG Secures EUR 11.51 Million Milestone Payment Financial Position BRAIN Biotech AG Milestone Payment Deucrictibant Royalty Pharma
PRESS RELEASE published on 09/09/2026 at 13:20, 27 days 16 hours ago BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma BRAIN Biotech AG receives EUR 11.51 million milestone payment from Royalty Pharma, enhancing financial position. Expecting additional future milestone payments. CFO sees positive developments Financial Position BRAIN Biotech AG Milestone Payment Royalty Pharma Future Milestones
BRIEF published on 09/09/2026 at 13:17, 27 days 16 hours ago BRAIN Biotech AG obtient 11,51 millions d'euros de Royalty Pharma BRAIN Biotech Impact Financier Paiement D'étape Deucrictibant Royal Pharma
BRIEF published on 09/09/2026 at 13:17, 27 days 16 hours ago BRAIN Biotech AG Secures EUR 11.51 Million from Royalty Pharma Financial Impact BRAIN Biotech Milestone Payment Deucrictibant Royalty Pharma
PRESS RELEASE published on 09/09/2026 at 13:12, 27 days 16 hours ago EQS-Adhoc: BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma BRAIN Biotech AG receives EUR 11.51 million milestone payment from Royalty Pharma for pharma compound development Development BRAIN Biotech AG Milestone Payment Royalty Pharma Pharma Compound
BRIEF published on 08/27/2026 at 07:35, 1 month 10 days ago BRAIN Biotech Reports 9M Results, Targets Break-even EBITDA Financial Results Revenue Forecast Revenue Decline EBITDA Target CEO Commentary
BRIEF published on 08/27/2026 at 07:35, 1 month 10 days ago BRAIN Biotech publie ses résultats des 9 derniers mois et vise un EBITDA à l'équilibre. Résultats Financiers Baisse Des Revenus Prévisions De Revenus Objectif EBITDA Commentaire Du PDG
PRESS RELEASE published on 08/27/2026 at 07:30, 1 month 10 days ago BRAIN Biotech reports its 9M results and continues to target a break-even adjusted Group-EBITDA BRAIN Biotech reports 9M results targeting break-even adjusted Group-EBITDA. BRAINBioIncubator forecast raised, BRAINBiocatalysts lowered. Detailed financial data and outlook included Adjusted EBITDA Financial Forecast Revenue Performance BRAIN Biotech 9M Results
BRIEF published on 07/29/2026 at 14:45, 2 months 8 days ago Dr. Sven K. Weber Appointed CEO of BRAIN Biotech AG CEO Appointment BRAIN Biotech AG Sven K. Weber Adriaan Moelker Enzyme Sector
Published on 10/07/2026 at 01:45, 3 hours 43 minutes ago Final Tunkillia Assays Among the Best Infill Results To-Date, with Broad, High-Grade Intersections Throughout 'Starter Pit' Outlines
Published on 10/07/2026 at 01:30, 3 hours 58 minutes ago ECC Ventures 4 Corp. Announces Resumption of Trading
Published on 10/07/2026 at 01:05, 4 hours 23 minutes ago Alaska Energy Metals Reports on At-The-Market Equity Financing Program
Published on 10/06/2026 at 23:45, 5 hours 43 minutes ago Gamma Resources Closes $1,750,000 Private Placement
Published on 10/06/2026 at 23:32, 5 hours 56 minutes ago Battery X Metals Announces Closing of First Tranche of Private Placement Financing
Published on 10/06/2026 at 19:05, 10 hours 22 minutes ago Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
Published on 10/06/2026 at 18:30, 10 hours 58 minutes ago Avolta’s Hudson secures new 20-year duty-free contract at Seattle-Tacoma International
Published on 10/06/2026 at 18:05, 11 hours 23 minutes ago Lepermislibre: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 10/06/2026 at 18:00, 11 hours 28 minutes ago ARVERNE GROUP: Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2026
Published on 10/06/2026 at 18:00, 11 hours 28 minutes ago ARVERNE GROUP: Total number of shares and voting rights in the share capital as of September 30, 2026
Published on 10/06/2026 at 19:15, 10 hours 13 minutes ago Air Liquide has successfully issued a 2 billion euros multi-tranche bond
Published on 10/06/2026 at 19:15, 10 hours 13 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 2 milliards d’euros
Published on 10/06/2026 at 18:39, 10 hours 48 minutes ago Capital et droits de vote au 30 septembre 2026
Published on 10/06/2026 at 18:39, 10 hours 48 minutes ago Total number of voting rights and shares making up the share capital at September 30, 2026
Published on 10/06/2026 at 18:15, 11 hours 13 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2026
